Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Pharmacogenomics|June 9, 2017
Should CYP2D6 be genotyped when treating with tamoxifen?Marzia Del Re, Eleonora Rofi, Valentina Citi, et al.
Eye (London, England)|February 6, 2018
Clinical pharmacology of intravitreal anti-VEGF drugsStefano Fogli, Marzia Del Re, Eleonora Rofi, et al.
Current Pharmaceutical Design|January 28, 2017
Pharmacogenetics and Metabolism from Science to Implementation in Clinical Practice: The Example of Dihydropyrimidine DehydrogenaseMarzia Del Re, Giuliana Restante, Antonello Di Paolo, et al.
Clinical Lung Cancer|June 12, 2017
Detection of ALK and KRAS Mutations in Circulating Tumor DNA of Patients With Advanced ALK-Positive NSCLC With Disease Progression During Crizotinib TreatmentPaola Bordi, Marcello Tiseo, Eleonora Rofi, et al.
Pharmacogenomics|May 23, 2018
EGFR-TKIs in non-small-cell lung cancer: focus on clinical pharmacology and mechanisms of resistanceStefano Fogli, Beatrice Polini, Marzia Del Re, et al.
BMC Cancer|May 2, 2019
The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case reportMarzia Del Re, Eleonora Rofi, Carla Cappelli, et al.
Oncotarget|February 22, 2018
Implications of KRAS mutations in acquired resistance to treatment in NSCLCMarzia Del Re, Eleonora Rofi, Giuliana Restante, et al.
Minerva Medica|May 19, 2025
Obesity and inflammatory response in moderate-to-severe acute respiratory distress syndrome: a single center pilot studyAdriano Peris, Marzia Del Re, Manuela Bonizzoli, et al.
Stem Cells (Dayton, Ohio)|January 21, 2018
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem CellsMarzia Del Re, Elena Arrigoni, Giuliana Restante, et al.
Stem Cells Translational Medicine|February 9, 2018
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic TreatmentElena Arrigoni, Marzia Del Re, Sara Galimberti, et al.
Pageof 3